Spreadex Market Update

Stocks drop further globally after negative comments from Moderna boss



European stocks have lost the small rebound gains they made yesterday, in response to revived fears of the Omicron variant affecting economic recovery.

This pressure was exacerbated after a warning from the head of leading vaccine maker, Moderna, that the current vaccines are most likely not going to be as effective against this new strain of Covid.

Deutsche Bank have attempted to calm the waters in a message sent out to clients, in which they state that this new variant is not a new development, and we have been on a steady trend of new virus waves throughout the year.

Having said this, throughout the day the markets have since regained some of these initial losses, FTSE, DAX and CAC currently -0.28%, -0.42% and -0.43% respectively.

Professor Karl Lauterbach, who is the running for Germany’s health minister, further added that it could be a ‘Christmas Gift’ due to the mild symptoms.

This split in opinions seems to be confusing most investors, hence why markets seem to be rising back up to being flat.

US markets seem to be following Europe again, as the general sentiment is quite negative thanks to both Moderna and Pfizer believing preliminarily, that their vaccines will be less potent, although they have said they need to do further research over the coming weeks.

SEARCH FOR AN ARTICLE:

Enter a keyword and search for all relevant articles

MARKET ANALYSIS

RECENT POSTS

Weekly Trading Update

Trading Week Ahead

Read More

Financial Trading Blog

UK Stocks Set Stage for Comeback

Read More

Daily Market Update

20.12.24 Friday Morning

Bitcoin soared 130% in 2024, hitting all-time highs due to favourable policies under the incoming Trump administration....

Read More

Economic Diary

20.12.24

Read More

Daily Market Update

19.12.24 Thursday Afternoon

UK equities present a mixed picture heading into the festive period, but certain sectors might outperform next...

Read More

Daily Market Update

19.12.24 Thursday Morning

The yen hit a one-month low against the dollar after the Bank of Japan held rates steady and provided no new guidance...

Read More

DISCLAIMER


Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 64% of retail investors lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. For professional clients, spread betting and CFD trading can also result in losses larger than your initial stake or deposit.

Spreadex Ltd is authorised and regulated by the Financial Conduct Authority, provides an execution only service and does not provide advice in any way. Nothing within this update should be deemed to constitute the provision of investment advice, recommendations, any other professional advice in any way, or a record of our trading prices. This update does not constitute or form part of an offer of, or solicitation for a transaction in any financial instrument, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract therefore. Any persons placing trades based on their interpretation of the comments or information within this update does so entirely at their own risk.

No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained within this update by Spreadex Ltd or any of its employees and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained within this update.

The information contained within this update is the intellectual property of Spreadex Ltd and is protected by UK and International copyright laws. All rights reserved. Users may however freely download, distribute and reproduce extracts of the contents, subject always to accrediting Spreadex Ltd as the source and providing a hyperlink to www.spreadex.com.